These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 7912072

  • 1. Absorption, distribution, metabolism and excretion of [14C]ebastine after repeated oral administration in rats.
    Fujii T, Tanaka K, Matsumoto S, Hatoyama T, Nomura N, Tagawa M, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):538-43. PubMed ID: 7912072
    [Abstract] [Full Text] [Related]

  • 2. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 3. Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats.
    Matsumoto S, Tagawa M, Hatoyama T, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1103-8. PubMed ID: 8267677
    [Abstract] [Full Text] [Related]

  • 4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 5. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M, Sakashita M, Mizuki Y, Yamaguchi T, Fujii T, Sekine Y.
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T, Hashizume T, Matsuda M, Sakashita M, Fujii T, Sekine Y, Nakashima M, Uematsu T.
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [Abstract] [Full Text] [Related]

  • 7. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H, Matsunaga Y, Nambu K, Oh-e Y, Yoshida K, Hashimoto M.
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T, Matsumoto S, Hatoyama T, Miyazaki H.
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K, Morino A, Nomura A, Iida S, Sugiyama M.
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [Abstract] [Full Text] [Related]

  • 12. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H, Sugimoto T, Ago M, Morino A, Takaichi M, Ogawa Y, Seki H, Matsuura C, Esumi Y.
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [Abstract] [Full Text] [Related]

  • 15. Identification of rat faecal metabolites of ebastine by B/E linked scanning liquid secondary ion mass spectrometry.
    Yoshida K, Hatoyama T, Fujii T, Kagemoto A, Miyazaki H, Naruto S.
    Biol Mass Spectrom; 1994 Jul; 23(7):385-90. PubMed ID: 7915143
    [Abstract] [Full Text] [Related]

  • 16. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
    Mizojiri K, Okabe H, Sugeno K, Esumi Y, Takaichi M, Tsutsumi S, Harada T, Miyoshi R, Inaba A.
    Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I, Rovati LC.
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [Abstract] [Full Text] [Related]

  • 19. Absorption, distribution, metabolism and excretion of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-difluoromethoxyphenyl)- 1,4-dihydropyridine (PP-1466) in rats.
    Inoue Y, Nakayama K, Wachi M, Kumakura K, Matsumoto T, Iwamoto M, Motoyoshi Y, Aikawa K.
    Arzneimittelforschung; 1985 Sep; 35(5):813-8. PubMed ID: 4026905
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H, Sugimoto T, Ago M, Morino A.
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.